keyword
https://read.qxmd.com/read/38650626/progress-of-medicinal-plants-and-their-active-metabolites-in-ischemia-reperfusion-injury-of-stroke-a-novel-therapeutic-strategy-based-on-regulation-of-crosstalk-between-mitophagy-and-ferroptosis
#21
REVIEW
Guozhen Zhang, Qiang Wang, Bing Jiang, Lihe Yao, Wenjuan Wu, Xiaoyan Zhang, Dongjun Wan, Youquan Gu
The death of cells can occur through various pathways, including apoptosis, necroptosis, mitophagy, pyroptosis, endoplasmic reticulum stress, oxidative stress, ferroptosis, cuproptosis, and disulfide-driven necrosis. Increasing evidence suggests that mitophagy and ferroptosis play crucial regulatory roles in the development of stroke. In recent years, the incidence of stroke has been gradually increasing, posing a significant threat to human health. Hemorrhagic stroke accounts for only 15% of all strokes, while ischemic stroke is the predominant type, representing 85% of all stroke cases...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38650409/-evaluation-of-the-effectiveness-of-various-regimens-of-the-immunomodulatory-drug-superlimf-in-the-prevention-of-relapses-of-chronic-abacterial-prostatitis
#22
JOURNAL ARTICLE
A Gyaurgiev T, V Kuzmenko A, V KuzmenkoV, V Zolotukhin O, Yu Madykin Yu, I Avdeev A
INTRODUCTION: Immune defense mechanisms, including a decrease in the functional activity of monocytes/macrophages, neutrophils, as well as a violation of the balance of pro- and anti-inflammatory cytokines, are important in the development of chronic abacterial prostatitis (CAP). The discovery of the cytokine system and the determination of their biological role in the development and functioning of the immune system and in the pathogenesis of a wide range of human diseases led to the development of a new direction in immunotherapy - cytokine therapy...
March 2024: Urologii︠a︡
https://read.qxmd.com/read/38649998/dengue-virus-pathogenesis-and-host-molecular-machineries
#23
REVIEW
Saumya Sinha, Kinjal Singh, Y S Ravi Kumar, Riya Roy, Sushant Phadnis, Varsha Meena, Sankar Bhattacharyya, Bhupendra Verma
Dengue viruses (DENV) are positive-stranded RNA viruses belonging to the Flaviviridae family. DENV is the causative agent of dengue, the most rapidly spreading viral disease transmitted by mosquitoes. Each year, millions of people contract the virus through bites from infected female mosquitoes of the Aedes species. In the majority of individuals, the infection is asymptomatic, and the immune system successfully manages to control virus replication within a few days. Symptomatic individuals may present with a mild fever (Dengue fever or DF) that may or may not progress to a more critical disease termed Dengue hemorrhagic fever (DHF) or the fatal Dengue shock syndrome (DSS)...
April 22, 2024: Journal of Biomedical Science
https://read.qxmd.com/read/38649659/bioinformatics-approach-to-identify-the-pathogenetic-link-of-gut-microbiota-derived-short-chain-fatty-acids-and-ischemic-stroke
#24
JOURNAL ARTICLE
Liang Ding, Jianing Wang, Sha Qiu, Zhizhen Ren, Yuantao Li, Pengpeng An
Stroke is a life-threatening condition that impairs the arteries and causes neurological impairment. The incidence of stroke is increasing year by year with the arrival of the aging population. Thus, there is an urgent need for early stroke diagnosis. Short-chain fatty acids (SCFAs) can modulate the central nervous system and directly and indirectly impact behavioral and cognitive functions. This study aimed to investigate the connection between SCFA metabolism and stroke development via bioinformatic analysis...
April 22, 2024: Molecular Neurobiology
https://read.qxmd.com/read/38649550/third-generation-solid-dispersion-based-formulation-of-novel-anti-tubercular-agent-exhibited-improvement%C3%A2-in-solubility-dissolution-and-biological-activity
#25
JOURNAL ARTICLE
Gourav Paudwal, Rigzin Dolkar, Summaya Perveen, Rashmi Sharma, Parvinder Pal Singh, Prem N Gupta
The long treatment period and development of drug resistance in tuberculosis (TB) necessitates the discovery of new anti-tubercular agents. The drug discovery program of the institute leads to the development of an anti-tubercular lead (IIIM-019), which is an analogue of nitrodihydroimidazooxazole and exhibited promising anti-tubercular action. However, IIIM-019 displays poor aqueous solubility (1.2 µg/mL), which demands suitable dosage form for its efficient oral administration. In the present study, third generation solid dispersion-based formulation was developed to increase the solubility and dissolution of IIIM-019...
April 22, 2024: AAPS Journal
https://read.qxmd.com/read/38649402/hbcvtr-an-end-to-end-transformer-with-a-deep-neural-network-hybrid-model-for-anti-hbv-and-hcv-activity-predictor-from-smiles
#26
JOURNAL ARTICLE
Ittipat Meewan, Jiraporn Panmanee, Nopphon Petchyam, Pichaya Lertvilai
Hepatitis B and C viruses (HBV and HCV) are significant causes of chronic liver diseases, with approximately 350 million infections globally. To accelerate the finding of effective treatment options, we introduce HBCVTr, a novel ligand-based drug design (LBDD) method for predicting the inhibitory activity of small molecules against HBV and HCV. HBCVTr employs a hybrid model consisting of double encoders of transformers and a deep neural network to learn the relationship between small molecules' simplified molecular-input line-entry system (SMILES) and their antiviral activity against HBV or HCV...
April 22, 2024: Scientific Reports
https://read.qxmd.com/read/38649381/tspan-protein-family-focusing-on-the-occurrence-progression-and-treatment-of-cancer
#27
REVIEW
Huhu Zhang, Qinghang Song, Kaiwen Shang, Ya Li, Liangqian Jiang, Lina Yang
The Tetraspanins (Tspan) protein family, also known as the tetraspanin family, contains 33 family members that interact with other protein molecules such as integrins, adhesion molecules, and T cell receptors by forming dimers or heterodimers. The Tspan protein family regulates cell proliferation, cell cycle, invasion, migration, apoptosis, autophagy, tissue differentiation, and immune response. More and more studies have shown that Tspan proteins are involved in tumorigenesis, epithelial-mesenchymal transition, thrombosis, tumor stem cell, and exosome signaling...
April 22, 2024: Cell Death Discovery
https://read.qxmd.com/read/38649362/hepatic-sirt6-activation-abrogates-acute-liver-failure
#28
JOURNAL ARTICLE
Jinque Luo, Huan Liu, Yanni Xu, Nanhui Yu, Rebbeca A Steiner, Xiaoqian Wu, Shuyi Si, Zheng Gen Jin
Acute liver failure (ALF) is a deadly illness due to insufficient detoxification in liver induced by drugs, toxins, and other etiologies, and the effective treatment for ALF is very limited. Among the drug-induced ALF, acetaminophen (APAP) overdose is the most common cause. However, the molecular mechanisms underlying APAP hepatoxicity remain incompletely understood. Sirtuin 6 (Sirt6) is a stress responsive protein deacetylase and plays an important role in regulation of DNA repair, genomic stability, oxidative stress, and inflammation...
April 22, 2024: Cell Death & Disease
https://read.qxmd.com/read/38649323/single-atom-iron-catalyst-as-an-advanced-redox-mediator-for-anodic-oxidation-of-organic-electrosynthesis
#29
JOURNAL ARTICLE
Xin-Yu Wang, Yong-Zhou Pan, Jiarui Yang, Wen-Hao Li, Tao Gan, Ying-Ming Pan, Hai-Tao Tang, Dingsheng Wang
Homogeneous electrocatalysts can indirect oxidate the high overpotential substrates through single-electron transfer on the electrode surface, enabling efficient operation of organic electrosynthesis catalytic cycles. However, the problems of this chemistry still exist such as high dosage, difficult recovery, and low catalytic efficiency. Single-atom catalysts (SACs) exhibit high atom utilization and excellent catalytic activity, hold great promise in addressing the limitations of homogeneous catalysts. In view of this, we have employed Fe-SA@NC as an advanced redox mediator to try to change this situation...
April 22, 2024: Angewandte Chemie
https://read.qxmd.com/read/38649263/a-retrospective-analysis-of-liraglutide-glp-1-agonist-use-in-a-chinchilla-chinchilla-lanigera-model-of-auditory-blast-injury
#30
JOURNAL ARTICLE
Deidra Marchi, Clarissa Cerepaka, Lori Garman, Wendy R Williams
Chinchillas are a relatively novel research model compared with other rodent species. They require special considerations when it comes to their husbandry and daily care. Chinchillas tend to be shy animals that are well adapted to masking clinical signs of illness. These characteristics can make them a difficult species to maintain in a research setting. The authors' institution has maintained chinchillas and established standardized daily animal care procedures for them. Chinchillas are most commonly used for auditory research...
April 22, 2024: Comparative Medicine
https://read.qxmd.com/read/38649181/towards-comprehensive-clinical-trials-for-new-tuberculosis-drug-regimens-policy-recommendations-from-a-stakeholder-analysis
#31
JOURNAL ARTICLE
Simone Villa, Pierpaolo de Colombani, Lucia Dall'Olio, Giuliano Gargioni, Mario Raviglione
BACKGROUND: Research and development (R&D) of new drugs and regimens against tuberculosis (TB) is evolving to meet new challenges and face limited investments in the sector. To effectively improve and fill existing gaps, researchers and trialists should engage a broad spectrum of stakeholders. With this study, we aim to map the interests in TB R&D raised by the main stakeholders in the TB field. METHODS: We conducted semistructured, short interviews to gather insight and viewpoints on innovation on TB drugs and regimens R&D of policy-makers, national TB programme officers, donors, funders, non-governmental organisations and research institutions...
April 22, 2024: BMJ Global Health
https://read.qxmd.com/read/38648941/navigating-the-future-microfluidics-charting-new-routes-in-drug-delivery
#32
REVIEW
Mohammad Mohammadi, Syamand Ahmed Qadir, Aryan Mahmood Faraj, Osama Hamid Shareef, Hassan Mahmoodi, Fatemeh Mahmoudi, Sajad Moradi
Microfluidics has emerged as a transformative force in the field of drug delivery, offering innovative avenues to produce a diverse range of nano drug delivery systems. Thanks to its precise manipulation of small fluid volumes and its exceptional command over the physicochemical characteristics of nanoparticles, this technology is notably able to enhance the pharmacokinetics of drugs. It has initiated a revolutionary phase in the domain of drug delivery, presenting a multitude of compelling advantages when it comes to developing nanocarriers tailored for the delivery of poorly soluble medications...
April 20, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38648904/generation-and-characterization-of-cytochrome-p450-3a74-crispr-cas9-knockout-bovine-foetal-hepatocyte-cell-line-bfh12
#33
JOURNAL ARTICLE
Silvia Iori, Caterina D'Onofrio, Nihay Laham-Karam, Isidore Mushimiyimana, Lorena Lucatello, Ludovica Montanucci, Rosa Maria Lopparelli, Federico Bonsembiante, Francesca Capolongo, Marianna Pauletto, Mauro Dacasto, Mery Giantin
In human, the cytochrome P450 3A (CYP3A) subfamily of drug-metabolizing enzymes (DMEs) is responsible for a significant number of phase I reactions, with the CYP3A4 isoform superintending the hepatic and intestinal metabolism of diverse endobiotic and xenobiotic compounds. The CYP3A4-dependent bioactivation of chemicals may result in hepatotoxicity and trigger carcinogenesis. In cattle, four CYP3A genes (CYP3A74, CYP3A76, CYP3A28 and CYP3A24) have been identified. Despite cattle being daily exposed to xenobiotics (e...
April 20, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38648855/breakthrough-therapy-cancer-drugs-and-indications-with-fda-approval-development-time-innovation-trials-clinical-benefit-epidemiology-and-price
#34
JOURNAL ARTICLE
Daniel Tobias Michaeli, Thomas Michaeli
BACKGROUND: The breakthrough therapy designation (BTD) facilitates the development of drugs with a large preliminary benefit in treating serious or life-threatening diseases. This study analyzes the FDA approval, trials, benefits, unmet needs, and pricing of breakthrough and nonbreakthrough therapy cancer drugs and indications. PATIENTS AND METHODS: We analyzed 355 cancer indications with FDA approval (2012-2022). Breakthrough and nonbreakthrough indications were compared regarding their FDA approval, innovativeness, clinical trials, epidemiology, and price...
April 22, 2024: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/38648728/research-strategies-of-small-molecules-as-chemotherapeutics-to-overcome-multiple-myeloma-resistance
#35
REVIEW
Jin Yang, Yan-Cheng Yu, Zi-Xuan Wang, Qing-Qing Li, Ning Ding, Xue-Jiao Leng, Jiao Cai, Meng-Yuan Zhang, Jing-Jing Wang, Yun Zhou, Tian-Hua Wei, Xin Xue, Wei-Chen Dai, Shan-Liang Sun, Ye Yang, Nian-Guang Li, Zhi-Hao Shi
Multiple myeloma (MM), a cancer of plasma cells, is the second most common hematological malignancy which is characterized by aberrant plasma cells infiltration in the bone marrow and complex heterogeneous cytogenetic abnormalities. Over the past two decades, novel treatment strategies such as proteasome inhibitors, immunomodulators, and monoclonal antibodies have significantly improved the relative survival rate of MM patients. However, the development of drug resistance results in the majority of MM patients suffering from relapse, limited treatment options and uncontrolled disease progression after relapse...
April 20, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38648653/covalent-polymer-rna-conjugates-for-potent-activation-of-the-rig-i-pathway
#36
JOURNAL ARTICLE
Christian R Palmer, Lucinda E Pastora, Blaise R Kimmel, Hayden M Pagendarm, Alexander J Kwiatkowski, Payton T Stone, Karan Arora, Nora Francini, Olga Fedorova, Anna M Pyle, John T Wilson
RNA ligands of retinoic acid-inducible gene I (RIG-I) are a promising class of oligonucleotide therapeutic with broad potential as antiviral agents, vaccine adjuvants, and cancer immunotherapies. However, their translation has been limited by major drug delivery barriers, including poor cellular uptake, nuclease degradation, and an inability to access the cytosol where RIG-I is localized. Here we address this challenge by engineering nanoparticles that harness covalent conjugation of 5'-triphospate RNA (3pRNA) to endosome-destabilizing polymers...
April 22, 2024: Advanced Healthcare Materials
https://read.qxmd.com/read/38648262/ophthalmological-and-neurological-findings-in-patients-with-idiopathic-uveitis-associated-with-retinal-vasculitis-and-the-relation-with-the-hla-dr15-allele
#37
JOURNAL ARTICLE
Vincent De Man, Sophie Bataillie, Catherine Cassiman, Lise Sels, Pieter-Paul Schauwvlieghe
PURPOSE: In 15 patients with idiopathic uveitis associated with retinal vasculitis, HLA DRB1 gene testing was performed to detect a possible association. 11 patients tested positive and 4 negative for the HLA DRB1 × 15 allele. The presence of the HLA DRB1 × 15 haplotype might be associated with a higher susceptibility to develop Multiple Sclerosis (MS). METHODS: In this case series, we describe the ophthalmological and neurological findings in 10 HLA DR15-positive patients and 4 HLA DR15-negative patients that had neurological workup, including Magnetic Resonance Imaging (MRI) of the brain...
April 22, 2024: Ocular Immunology and Inflammation
https://read.qxmd.com/read/38648052/revisiting-drug-protein-interaction-prediction-a-novel-global-local-perspective
#38
JOURNAL ARTICLE
Zhecheng Zhou, Qingquan Liao, Jinhang Wei, Linlin Zhuo, Xiaonan Wu, Xiangzheng Fu, Quan Zou
MOTIVATION: Accurate inference of potential Drug-protein interactions (DPIs) aids in understanding drug mechanisms and developing novel treatments. Existing deep learning models, however, struggle with accurate node representation in DPI prediction, limiting their performance. RESULTS: We propose a new computational framework that integrates global and local features of nodes in the drug-protein bipartite graph for efficient DPI inference. Initially, we employ pre-trained models to acquire fundamental knowledge of drugs and proteins and to determine their initial features...
April 22, 2024: Bioinformatics
https://read.qxmd.com/read/38647430/identifying-and-assessing-putative-allosteric-sites-and-modulators-for-cxcr4-predicted-through-network-modeling-and-site-identification-by-ligand-competitive-saturation
#39
JOURNAL ARTICLE
Tugce Inan, Robin Flinko, George K Lewis, Alexander D MacKerell, Ozge Kurkcuoglu
The chemokine receptor CXCR4 is a critical target for the treatment of several cancer types and HIV-1 infections. While orthosteric and allosteric modulators have been developed targeting its extracellular or transmembrane regions, the intramembrane region of CXCR4 may also include allosteric binding sites suitable for the development of allosteric drugs. To investigate this, we apply the Gaussian Network Model (GNM) to the monomeric and dimeric forms of CXCR4 to identify residues essential for its local and global motions located in the hinge regions of the protein...
April 22, 2024: Journal of Physical Chemistry. B
https://read.qxmd.com/read/38647399/hybrid-membrane-coated-nanoparticles-for-precise-targeting-and-synergistic-therapy-in-alzheimer-s-disease
#40
JOURNAL ARTICLE
Rong-Rong Lin, Lu-Lu Jin, Yan-Yan Xue, Zhe-Sheng Zhang, Hui-Feng Huang, Dian-Fu Chen, Qian Liu, Zheng-Wei Mao, Zhi-Ying Wu, Qing-Qing Tao
The blood brain barrier (BBB) limits the application of most therapeutic drugs for neurological diseases (NDs). Hybrid cell membrane-coated nanoparticles derived from different cell types can mimic the surface properties and functionalities of the source cells, further enhancing their targeting precision and therapeutic efficacy. Neuroinflammation has been increasingly recognized as a critical factor in the pathogenesis of various NDs, especially Alzheimer's disease (AD). In this study, a novel cell membrane coating is designed by hybridizing the membrane from platelets and chemokine (C-C motif) receptor 2 (CCR2) cells are overexpressed to cross the BBB and target neuroinflammatory lesions...
April 22, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
keyword
keyword
170211
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.